Glenmede Trust’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-7,877
| Closed | -$658K | – | 1453 |
|
2024
Q4 | $658K | Sell |
7,877
-3,592
| -31% | -$300K | ﹤0.01% | 838 |
|
2024
Q3 | $839K | Sell |
11,469
-1,289
| -10% | -$94.3K | ﹤0.01% | 770 |
|
2024
Q2 | $874K | Buy |
+12,758
| New | +$874K | ﹤0.01% | 729 |
|
2020
Q4 | – | Sell |
-99
| Closed | -$2K | – | 2314 |
|
2020
Q3 | $2K | Buy |
99
+55
| +125% | +$1.11K | ﹤0.01% | 2298 |
|
2020
Q2 | $1K | Buy |
+44
| New | +$1K | ﹤0.01% | 2392 |
|
2017
Q3 | – | Sell |
-19,410
| Closed | -$315K | – | 2861 |
|
2017
Q2 | $315K | Hold |
19,410
| – | – | ﹤0.01% | 1063 |
|
2017
Q1 | $315K | Hold |
19,410
| – | – | ﹤0.01% | 1063 |
|
2016
Q4 | $292K | Buy |
19,410
+11,762
| +154% | +$177K | ﹤0.01% | 1103 |
|
2016
Q3 | $116K | Buy |
+7,648
| New | +$116K | ﹤0.01% | 1359 |
|